Related Experiment Video
Updated: Mar 15, 2026

08:09
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
8.0K
Quantitative Susceptibility Mapping in Parkinson's Disease.
Christian Langkammer1, Lukas Pirpamer1, Stephan Seiler1
1Department of Neurology, Medical University of Graz, Graz, Austria.
Plos One
|September 7, 2016
Summary
Quantitative susceptibility mapping (QSM) reveals widespread iron deposition changes in Parkinson's disease (PD) beyond the substantia nigra. This advanced MRI technique shows greater sensitivity for detecting PD-related tissue alterations and correlates with disease severity and medication.
Area of Science:
- Neuroimaging
- Medical Physics
- Neurology
Background:
- Iron deposition in the substantia nigra is linked to Parkinson's disease (PD) using Quantitative Susceptibility Mapping (QSM) and R2* mapping.
- Previous studies show conflicting findings in other deep gray matter nuclei and limited investigation into QSM/R2* sensitivity for morphological changes and clinical correlations.
Purpose of the Study:
- To investigate the sensitivity of QSM and R2* mapping for detecting morphological changes in subcortical deep gray matter nuclei in PD.
- To explore the relationship between QSM/R2* findings and clinical measures of PD severity.
Main Methods:
- Quantitative MRI at 3T was performed on 66 PD patients and 58 controls.
- Susceptibility and R2* maps were reconstructed using a spoiled multi-echo 3D gradient echo sequence.
- Mean susceptibilities and R2* rates were measured in subcortical deep gray matter nuclei and correlated with clinical variables.
Main Results:
- PD patients showed increased R2* in the substantia nigra compared to controls.
- QSM revealed higher magnetic susceptibilities in PD patients in the substantia nigra, nucleus ruber, thalamus, and globus pallidus.
- Magnetic susceptibility in several regions correlated with levodopa-equivalent daily dose (LEDD) and clinical markers (MDS-UPDRS), and Hoehn & Yahr scale scores.
Conclusions:
- QSM demonstrated superior sensitivity for PD-related tissue changes in nigrostriatal pathways compared to R2*.
- QSM findings correlated with levodopa dosage and disease severity, suggesting widespread pathology.
- QSM represents a novel, highly sensitive MRI technique for investigating PD.

